These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2164099)

  • 21. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
    Goering J; Zimmerman BG
    J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha 1-adrenoceptor blockade and altered renal alpha 2-adrenoceptors: a model(?) for the study of genetically altered alpha 2-adrenoceptors in hypertensive rats.
    Smyth DD; Umemura S; Pettinger WA
    J Hypertens Suppl; 1986 Oct; 4(3):S205-8. PubMed ID: 3023587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
    Bohmann C; Rist W; Schollmeyer P; Rump LC
    Cardiovasc Res; 1995 Dec; 30(6):857-65. PubMed ID: 8746199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose selective dissociation of water and solute excretion after renal alpha-2 adrenoceptor stimulation.
    Blandford DE; Smyth DD
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1181-6. PubMed ID: 2849664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
    Nichols AJ; Hamada A; Adejare A; Miller DD; Patil PN; Ruffolo RR
    J Pharmacol Exp Ther; 1989 Feb; 248(2):671-6. PubMed ID: 2537407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.
    Sager G; Jaeger R; Little C
    Br J Clin Pharmacol; 1989 Feb; 27(2):229-34. PubMed ID: 2713217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of a chemically reactive prazosin analog with alpha-1 adrenoceptors of rat tissues.
    Kusiak JW; Pitha J; Piascik MT
    J Pharmacol Exp Ther; 1989 Apr; 249(1):70-7. PubMed ID: 2565396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does alpha 1-acid glycoprotein act as a non-functional receptor for alpha 1-adrenergic antagonists?
    Qin M; Oie S
    J Pharm Pharmacol; 1994 Nov; 46(11):896-901. PubMed ID: 7897595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alpha-1-acid glycoprotein administration on propranolol binding and beta blockade in rats.
    Keyler DE; Pentel PR
    Biochem Pharmacol; 1989 Apr; 38(7):1163-8. PubMed ID: 2539818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of altered albumin concentrations on elimination of unbound prazosin in vivo in the rat and in the isolated perfused rat liver.
    Oie S; Yang YH
    J Pharm Sci; 1988 Nov; 77(11):948-51. PubMed ID: 3225755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    Pharm Res; 2001 Jun; 18(6):838-45. PubMed ID: 11474789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of prazosin to alpha 1-acid glycoprotein and albumin: effect of protein purity and concentrations.
    Sager G; Jaeger R; Little C
    Pharmacol Toxicol; 1989 Apr; 64(4):365-8. PubMed ID: 2748545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and toxicity of high-dose human alpha 1-acid glycoprotein infusion in the rat.
    Keyler DE; Pentel PR; Haughey DB
    J Pharm Sci; 1987 Feb; 76(2):101-4. PubMed ID: 3572744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of alpha 1-acidglycoprotein on myocardial uptake and pharmacodynamics of quinidine in perfused rat heart.
    Huang JL; Morgan DJ
    Biochem Pharmacol; 1993 Nov; 46(10):1705-11. PubMed ID: 8250956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus.
    Trovik TS; Jaeger R; Jorde R; Ingebretsen O; Sager G
    Eur J Clin Pharmacol; 1992; 43(3):265-8. PubMed ID: 1425889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparison of alpha 1-acid glycoprotein (AAG) concentration and disopyramide binding in Chinese and Japanese].
    Jin EZ
    Hokkaido Igaku Zasshi; 1999 Jul; 74(4):279-88. PubMed ID: 10480035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple method for the simulation of unbound serum disopyramide concentration in patients.
    Kishino S; Kohri N; Iseki K; Miyazaki K; Nomura A; Yasuda H
    J Pharmacobiodyn; 1991 Sep; 14(9):493-9. PubMed ID: 1779403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.